6-Hydroxydopamine lesion of locus coeruleus and the antiparkinsonian potential of NMDA-receptor antagonists in rats

Journal of Neural Transmission

Volumn 104, Issue 4-5, 1997, Pages 363-377

  Ruckert N ^a   Bubser, M ^a,b   Schmidt, W J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 OHDA lesion; Behavior; Exploration; HPLC; L DOPA; Locomotion; Locus coeruleus; NMDA receptor antagonists; Noradrenaline; Open field; Parkinson's disease; Rat

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; DIZOCILPINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; LEVODOPA; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NORADRENALIN; OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; EXPLORATORY BEHAVIOR; INTRAPERITONEAL DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MOTOR DYSFUNCTION; NERVE LESION; NEUROCHEMISTRY; NONHUMAN; OPEN FIELD BEHAVIOR; PARKINSONISM; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ADRENERGIC AGENTS; ANIMALS; ANTIPARKINSON AGENTS; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; LOCUS COERULEUS; MALE; MOTOR ACTIVITY; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0030880461     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01277657     Document Type: Article

References (42)

1. Abercrombie ED, Bonatz AE, Zigmond MJ (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525: 36-44
2. Andén NE, Grabowska M (1976) Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol 39: 275-282
3. Antonoou K, Kafetzopoulos E (1991) A comparative study of the behavioral effects of d-amphetamine and apomorphine in the rat. Pharmacol Biochem Behav 39: 61-70
4. Aston-Jones G, Shipley MT, Grzanna R (1995) The locus coeruleus, A5 and A7 noradrenergic cell groups. In: Paxinos G (ed) The rat nervous system, 2nd edn. Academic Press, San Diego, pp 183-213
5. Blanc G, Trovero F, Vezina P, Hervé D, Godeheu AM, Glowinski J, Tassin JP (1994) Blockade of prefronto-cortical α1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical d-amphetamine injection. Eur J Neurosci 6: 293-298
6. Bubser M, Keseberg U, Notz PK, Schmidt WJ (1992) Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol 229: 75-82
7. Carlsson M, Carlsson A (1990) Interaction between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci 13: 272-276
8. Collingridge GL, James TA, MacLeod NK (1979) Neurochemical and electrophysiological evidence for a projection from the locus coeruleus to the substantia nigra. J Physiol (Lond) 290: 44P
9. Colpaert FC (1987) Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology 26: 1431-1440
10. Colpaert FC (1994) Noradrenergic mechanisms in Parkinson's disease: a theory. In: Briley M, Marien M (eds) Noradrenergic mechanisms in Parkinson's disease. CRC Press, Boca Raton, pp 225-254 (Pierre Fabre Monograph Series)
11. Colpaert FC, Degryse A-D, van Craenendonck H (1991) Effects of an alpha2 antagonist in a 2-year-old Java monkey with MPTP-induced parkinsonian signs. Brain Res Bull 26: 627-631
12. Danysz W, Gossel M, Zajaczkowski W, Dill D, Quack G (1994a) Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats? Case of amantadine and memantine. J Neural Transm [PD Sect] 7: 155-166
13. Danysz W, Essmann U, Bresink I, Wilke R (1994b) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 48: 111-118
14. 2-Adrenoreceptor antagonists differentialy influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat. Psychopharmacology 96: 521-527
15. Farley IJ, Hornykiewicz O (1977) Noradrenaline distribution in subcortical areas of the human brain. Brain Res 126: 53-62
16. Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus coeruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63: 844-914
17. Fredriksson A, Gentsch C, Archer T (1994) Synergistic interactions between NMDA-antagonists and L-DOPA on activity in MPTP-treated mice. J Neural Transm [Gen Sect] 97: 197-209
18. German DC, Manaye KF, White CL III, Woodward DJ, McIntire DD, Smith WK, Kalaria RN, Mann DMA (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32: 667-676
19. Greenamyre JT (1993) Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease. J Neural Transm [Gen Sect] 91: 255-269
20. Heffner TG, Hartman JA, Seiden LS (1980) A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 3: 453-456
21. Jellinger KA (1991) Pathology of Parkinson's disease: changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14: 153-197
22. 125I]-HEAT. J Comp Neurol 231: 190-208
23. Kornhuber J, Weller M, Schoppmeyer K, Riederer P (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm [Suppl] 43: 91-104
24. Kostowski W, Jerlicz M, Bidzinski A, Hauptmann M (1977) Behavioral effects of neuroleptics, apomorphine and amphetamine after bilateral lesions of the locus coeruleus in rats. Pharmacol Biochem Behav 7: 289-293
25. Kostowski W, Jerlicz M, Bidzinski A, Hauptmann M (1978) Evidence for existence of two opposite noradrenergic brain systems controlling behavior. Psychopharmacology 59: 311-312
26. Lategan AJ, Marien MR, Colpaert FC (1990) Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis. Brain Res 523: 134-138
27. Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colpaert FC (1991) Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience 41: 507-523
28. Moryl E, Danysz W, Quack G (1993) Potential antidepressive properties of amantadine, memantine and bifemelane. Pharmacol Toxicol 72: 394-397
29. Nicholas AP, Hökfelt T, Pieribone VA (1996) The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol Sci 17: 245-255
30. 2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology 111: 427-434
31. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, London
32. Pijnenburg AJJ, Honig WMM, van Rossum JM (1974) Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacologia (Berl) 41: 175-180
33. Rabey JM, Nissipeanu P, Korczyn AD (1992) Efficacy of memantine, and NMDA receptor antgonists, in the treatment of Parkinson's disease. J Neural Transm [PD Sect] 4: 277-282
34. Riederer P, Birkmayer W, Seeman D, Wuketich S (1977) Brain noradrenaline and 3-methyoxy-4-hydroxyphenylglycol in Parkinson's disease. J Neural Transm 41: 241-251
35. Robbins TTW, Jones GGH (1992) Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity. Pharmacol Biochem Behav 43: 887-895
36. Rückert NGH, Schmidt WJ (1993) The σ receptor ligand 1,3-di-(2-toly)guanidine in animal models of schizophrenia. Eur J Pharmacol 233: 261-267
37. Schmidt WJ (1986) Intrastriatal injection of DL-2-amino-5-phosphono-valeric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology 90: 123-130
38. Schmidt WJ, Bubser M, Hauber W (1992) Behavioural pharmacology of glutamate in the basal ganglia. J Neural Transm [Suppl] 38: 65-89
39. Sommermeyer H, Frielingsdorf J, Knorr A (1995) Effects of prazosin on the dopaminergic neurotransmission in rat brain. Eur J Pharmacol 276: 267-270
40. Starr MS, Starr BS (1995) Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist. J Neural Transm [P-D Sect] 9: 31-43
41. 1-adrenergic receptor subtype to the expression of the "ventral tegmental area syndrome". Neuroscience 47: 69-76
42. Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen JC (1993) The locus coeruleus and dementia in Parkinson's disease. Neurology 43: 986-991